Financial Statements — UDMY
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 |
|---|
| Cash & Equivalents | 252.56 | 235.93 | 230.26 | 189.62 | 204.56 | 272.36 | 256.81 | 327.97 | 323.23 | 275.63 | 427.91 | 512.17 | 510.97 | 130.18 |
| Short-term Investments | 105.26 | 135.29 | 161.72 | 167.40 | 152.55 | 148.56 | 173.88 | 151.47 | 142.29 | 169.61 | 66.05 | -- | -- | -- |
| Accounts Receivable | 97.14 | 76.56 | 84.44 | 111.17 | 81.16 | 82.08 | 99.77 | 82.86 | 87.00 | 96.42 | 71.58 | 69.31 | 67.70 | 40.66 |
| Total Current Assets | 533.63 | 524.14 | 547.50 | 541.06 | 508.01 | 567.90 | 603.43 | 621.71 | 605.34 | 595.02 | 608.40 | 622.22 | 617.02 | 205.95 |
| Property, Plant & Equipment | 6.40 | 6.98 | 7.19 | 6.77 | 3.32 | 3.84 | 4.07 | 4.98 | 5.49 | 6.21 | 7.82 | 8.29 | 8.94 | 10.59 |
| Goodwill | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 | 12.65 |
| Intangible Assets | 2.03 | 2.87 | 3.28 | 2.20 | 2.66 | 3.31 | 4.27 | 6.18 | 7.20 | 8.26 | 10.40 | 11.46 | 12.53 | 14.71 |
| Total Non-current Assets | 15.09 | 17.09 | 16.29 | 16.80 | 15.15 | 16.59 | 8.27 | 12.13 | 14.07 | 16.02 | 20.69 | 8.20 | 8.83 | 10.44 |
| Total Assets | 634.59 | 618.90 | 643.96 | 638.99 | 608.91 | 671.94 | 708.45 | 736.49 | 722.14 | 716.90 | 730.39 | 745.99 | 738.89 | 289.96 |
| Accounts Payable | 12.89 | 6.53 | 7.41 | 4.43 | 4.27 | 3.67 | 3.08 | 5.66 | 5.31 | 10.79 | 17.06 | 17.32 | 16.27 | 26.22 |
| Total Current Liabilities | 416.15 | 389.18 | 402.67 | 420.32 | 402.85 | 408.84 | 408.29 | 386.45 | 383.53 | 382.53 | 358.25 | 353.87 | 339.60 | 276.95 |
| Total Non-current Liabilities* | 6.26 | 7.92 | 7.93 | 9.32 | 9.79 | 10.84 | 3.68 | 4.20 | 5.49 | 9.29 | 15.63 | 17.17 | 18.78 | 5.54 |
| Total Liabilities | 422.41 | 397.09 | 410.60 | 429.63 | 412.65 | 419.69 | 411.96 | 390.66 | 389.02 | 391.82 | 373.88 | 371.04 | 358.38 | 282.50 |
| Retained Earnings | (813.79) | (798.85) | (800.49) | (806.76) | (795.12) | (769.85) | (738.04) | (699.45) | (682.68) | (656.95) | (560.25) | (513.56) | (484.18) | (417.14) |
| Total Stockholder Equity | 212.18 | 221.81 | 233.36 | 209.36 | 196.26 | 252.25 | 296.49 | 345.84 | 333.12 | 325.08 | 356.52 | 374.95 | 380.51 | (266.81) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Total Revenue | 191.41 | 193.99 | 195.68 | 199.88 | 200.30 | 199.94 | 195.42 | 194.36 | 196.85 | 189.55 | 184.72 | 178.24 | 176.43 | 165.33 | 158.43 | 153.11 | 152.22 | 135.45 | 129.56 |
| Cost of Revenue | 62.14 | 65.94 | 66.81 | 67.83 | 70.86 | 72.74 | 72.36 | 73.24 | 76.28 | 79.69 | 77.26 | 75.94 | 76.70 | 73.99 | 69.08 | 65.81 | 66.44 | 64.12 | 57.99 |
| Gross Profit | 129.27 | 128.05 | 128.87 | 132.05 | 129.44 | 127.21 | 123.06 | 121.12 | 120.56 | 109.85 | 107.46 | 102.30 | 99.73 | 91.34 | 89.35 | 87.30 | 85.79 | 71.33 | 71.58 |
| Research & Development | 26.79 | 24.61 | 25.58 | 26.36 | 24.96 | 28.83 | 32.98 | 32.41 | 31.22 | 29.51 | 30.31 | 29.64 | 30.89 | 29.96 | 28.06 | 23.96 | 22.57 | 19.21 | 16.70 |
| Selling, General & Admin | 25.39 | 24.24 | 21.94 | 21.83 | 25.01 | 21.90 | 22.27 | 27.26 | 24.77 | 22.79 | 22.16 | 22.62 | 26.33 | 26.92 | 27.05 | 23.44 | 21.65 | 22.44 | 12.17 |
| Total Operating Expenses | 141.79 | 131.48 | 129.03 | 128.12 | 133.94 | 138.80 | 152.51 | 146.66 | 143.29 | 135.51 | 128.95 | 129.76 | 147.01 | 145.44 | 132.60 | 115.83 | 111.10 | 112.27 | 81.13 |
| Operating Income | (12.53) | (3.43) | (0.16) | 3.93 | (4.49) | (11.59) | (29.46) | (25.55) | (22.73) | (25.66) | (21.50) | (27.46) | (47.28) | (54.10) | (43.25) | (28.53) | (25.32) | (40.94) | (9.55) |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.05 | 0.12 | -- | -- | -- | -- | -- | -- | -- | 0.06 |
| Pretax Income | (10.56) | (0.98) | 2.75 | 7.40 | (0.83) | (8.21) | (24.41) | (31.01) | (17.31) | (19.52) | (15.96) | (24.68) | (43.49) | (51.02) | (46.18) | (29.07) | (25.32) | (40.72) | (9.81) |
| Tax Provision | 2.05 | 1.35 | 1.11 | 1.13 | 0.94 | 1.66 | 0.86 | 0.80 | 1.03 | 0.73 | 0.81 | 1.06 | 1.06 | 1.14 | 0.51 | 0.31 | 0.33 | 0.67 | (0.55) |
| Net Income | (12.61) | (2.33) | 1.64 | 6.27 | (1.77) | (9.86) | (25.27) | (31.81) | (18.34) | (20.25) | (16.77) | (25.73) | (44.54) | (52.15) | (46.69) | (29.38) | (25.65) | (41.38) | (9.26) |
| Basic EPS | (0.09) | (0.01) | 0.01 | 0.04 | (0.01) | (0.06) | (0.17) | (0.21) | (0.12) | (0.12) | (0.11) | (0.17) | (0.31) | (0.37) | (0.33) | (0.21) | (0.18) | (0.42) | (0.25) |
| Diluted EPS | (0.09) | (0.01) | 0.01 | 0.04 | (0.01) | (0.06) | (0.17) | (0.21) | (0.12) | (0.12) | (0.11) | (0.17) | (0.31) | (0.37) | (0.33) | (0.21) | (0.18) | (0.42) | (0.25) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Operating Cash Flow | 15.44 | 15.52 | 15.73 | 44.20 | 12.21 | 9.58 | (6.10) | 28.59 | 20.97 | (7.27) | 11.67 | 13.49 | (19.89) | (30.68) | (13.84) | (2.46) | (13.97) | 2.32 | (9.42) |
| Capital Expenditures | 0.55 | 0.52 | 0.62 | 2.28 | 2.38 | 1.18 | 0.56 | 0.36 | 0.20 | 0.20 | 0.19 | 0.14 | 0.10 | 0.17 | 0.70 | 0.54 | 0.16 | 0.78 | 4.55 |
| Free Cash Flow* | 14.89 | 14.99 | 15.11 | 41.92 | 9.83 | 8.40 | (6.66) | 28.24 | 20.77 | (7.46) | 11.48 | 13.35 | (19.99) | (30.85) | (14.53) | (3.00) | (14.13) | 1.54 | (13.97) |
| Investing Cash Flow | 9.08 | 4.84 | 23.41 | (0.20) | (7.41) | (13.13) | (5.70) | 23.68 | (3.77) | (20.98) | (10.40) | 25.72 | (19.32) | (88.55) | (72.33) | (4.07) | (8.28) | (13.88) | (38.81) |
| Financing Cash Flow | (2.92) | (25.60) | (33.46) | (3.49) | (5.91) | (10.25) | (56.08) | (38.95) | (66.46) | 6.16 | 3.57 | 8.29 | 1.18 | 4.99 | 1.95 | 7.74 | 0.07 | 415.26 | 3.38 |
* Derived from reported values
